Jiangzhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000M80
CNY
25.83
-0.16 (-0.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jiangzhong Pharmaceutical Co., Ltd.

Why is Jiangzhong Pharmaceutical Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 11.68% and Operating profit at 15.28% over the last 5 years
2
Flat results in Dec 25
  • RAW MATERIAL COST(Y) Grown by 101.88% (YoY)
  • DEBT-EQUITY RATIO (HY) Highest at 0 %
  • DEBTORS TURNOVER RATIO(HY) Lowest at 0 times
3
With ROE of 22.88%, it has a very attractive valuation with a 3.51 Price to Book Value
  • Over the past year, while the stock has generated a return of 16.21%, its profits have risen by 12.2% ; the PEG ratio of the company is 1.2
  • At the current price, the company has a high dividend yield of 5.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Jiangzhong Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiangzhong Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Jiangzhong Pharmaceutical Co., Ltd.
13.49%
-0.27
16.45%
China Shanghai Composite
15.17%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.68%
EBIT Growth (5y)
15.28%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.06
Tax Ratio
15.82%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.69%
ROE (avg)
16.29%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.51
EV to EBIT
13.18
EV to EBITDA
11.41
EV to Capital Employed
4.80
EV to Sales
2.88
PEG Ratio
1.23
Dividend Yield
5.46%
ROCE (Latest)
36.47%
ROE (Latest)
22.88%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
ROCE(HY)

Highest at 21.48%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

NET SALES(Q)

At CNY 1,286.33 MM has Grown at 17.03%

-5What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 101.88% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 0 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

DIVIDEND PER SHARE(HY)

Lowest at CNY 0

EPS(Q)

Lowest at CNY 0

Here's what is working for Jiangzhong Pharmaceutical Co., Ltd.

Net Sales
At CNY 1,286.33 MM has Grown at 17.03%
over average net sales of the previous four periods of CNY 1,099.19 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Jiangzhong Pharmaceutical Co., Ltd.

EPS
Lowest at CNY 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend per share
Lowest at CNY 0
in the last five years
MOJO Watch
Company is distributing lower dividend than previous years

DPS (CNY)

Raw Material Cost
Grown by 101.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales